In silico analysis of the structure of variable domains of mouse single-chain antibodies specific to the human recombinant interferon β1b
Andrew I. Flyak(Vanderbilt University), Pavlo Gilchuk(AstraZeneca (Japan)), M. V. Pavlova(Taras Shevchenko National University of Kyiv)
Cited by 0
Related Papers
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k